These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9823701

  • 1. [Insulin resistance in polycystic ovary syndrome].
    Aquino Carlos P, Hernández Valencia M.
    Ginecol Obstet Mex; 1998 Nov; 66():446-51. PubMed ID: 9823701
    [Abstract] [Full Text] [Related]

  • 2. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.
    Barbieri RL.
    J Reprod Med; 1994 May; 39(5):327-36. PubMed ID: 8064699
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance in polycystic ovary syndrome.
    Prelevic GM.
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E, Papavassiliou AG.
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [Abstract] [Full Text] [Related]

  • 5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 6. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E, Kiapekou E, Loutradis D.
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG, Patchava S, Laing I.
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [Abstract] [Full Text] [Related]

  • 8. Polycystic ovary syndrome.
    Goudas VT, Dumesic DA.
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [Abstract] [Full Text] [Related]

  • 9. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.
    Barbieri RL, Hornstein MD.
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472
    [Abstract] [Full Text] [Related]

  • 10. [Polycystic ovary syndrome].
    Dewailly D.
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
    [Abstract] [Full Text] [Related]

  • 11. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F, Palomba S, Vigorito C, Tafuri MG, Colao A, Lombardi G, Orio F.
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V, Musacchio MC, Morgante G, La Marca A, Petraglia F.
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [Abstract] [Full Text] [Related]

  • 13. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
    Balen A.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
    [Abstract] [Full Text] [Related]

  • 14. [Hyperandrogenic states in women (polycystic ovary syndrome) and insulin resistance].
    Kreze A, Hrnciar J, Dobáková M.
    Vnitr Lek; 1995 Feb; 41(2):126-8. PubMed ID: 7725637
    [Abstract] [Full Text] [Related]

  • 15. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA, Hernández Marín I, Ayala AR.
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [Abstract] [Full Text] [Related]

  • 16. Use of insulin sensitizers in polycystic ovarian syndrome.
    Baillargeon JP.
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
    [Abstract] [Full Text] [Related]

  • 17. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B, Gambineri A, Pasquali R.
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [Abstract] [Full Text] [Related]

  • 18. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
    Schuring AN, Schulte N, Sonntag B, Kiesel L.
    Gynakol Geburtshilfliche Rundsch; 2008 Feb; 48(1):9-15. PubMed ID: 18209494
    [Abstract] [Full Text] [Related]

  • 19. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A.
    Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
    [Abstract] [Full Text] [Related]

  • 20. Androgen circle of polycystic ovary syndrome.
    Homburg R.
    Hum Reprod; 2009 Jul; 24(7):1548-55. PubMed ID: 19279033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.